期刊
SCIENCE SIGNALING
卷 6, 期 265, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scisignal.2003398
关键词
-
资金
- Huntsman Cancer Institute, University of Utah CRR Program
- National Heart, Lung, and Blood Institute (NHLBI)
- Juvenile Diabetes Research Foundation
- Rocky Mountain Regional Center for Excellence in Biodefense and Emerging Infectious Disease
- American Asthma Foundation
- Department of Defense
- R. L. Kirschstein NRSA from NHLBI [2T32HL007576-26]
- National Cancer Institute
- University of Notre Dame SAPC Program
- University of Notre Dame Graduate Assistantship
beta-Catenin has a dual function in cells: fortifying cadherin-based adhesion at the plasma membrane and activating transcription in the nucleus. We found that in melanoma cells, WNT5A stimulated the disruption of N-cadherin and beta-catenin complexes by activating the guanosine triphosphatase adenosine diphosphate ribosylation factor 6 (ARF6). Binding of WNT5A to the Frizzled 4-LRP6 (low-density lipoprotein receptor-related protein 6) receptor complex activated ARF6, which liberated beta-catenin from N-cadherin, thus increasing the pool of free beta-catenin, enhancing beta-catenin-mediated transcription, and stimulating invasion. In contrast to WNT5A, the guidance cue SLIT2 and its receptor ROBO1 inhibited ARF6 activation and, accordingly, stabilized the interaction of N-cadherin with beta-catenin and reduced transcription and invasion. Thus, ARF6 integrated competing signals in melanoma cells, thereby enabling plasticity in the response to external cues. Moreover, small-molecule inhibition of ARF6 stabilized adherens junctions, blocked beta-catenin signaling and invasiveness of melanoma cells in culture, and reduced spontaneous pulmonary metastasis in mice, suggesting that targeting ARF6 may provide a means of inhibiting WNT/beta-catenin signaling in cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据